Skip to main content
OpenTrials

Clinical trial condition

Recurrent Distal Bile Duct Adenocarcinoma

Explore clinical trials studying Recurrent Distal Bile Duct Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Distal Bile Duct Adenocarcinoma trial results

Active, Not Recruiting

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

NCT04941287

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +20 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 29 locations
View Trial Details

Related conditions